DISEASE INDICATIONS: Skin Cancer

MANUFACTURER: Sun Pharmaceutical Industries Europe B.V.

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Therapeutic Goods Administration (TGA)

Odomzo (sonidegib) is a medication used to treat locally advanced basal cell carcinoma (BCC). It is taken once daily at two possible dosages – 200mg or 800mg.